Skip to content

Obesity and asthma: long-term effect of bariatric surgery on lung function, inflammation and quality of life

Obesity and asthma: long-term effect of bariatric surgery on lung function, inflammation and quality of life - Obesity and asthma: long-term effects of bariatric surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57698
Enrollment
105
Registered
2017-12-08
Start date
2018-01-05
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesitas Asthma bronchial hyperreactivity

Interventions

None listed

Sponsors

Sint Franciscus Gasthuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients who fullfilled the inclusion criteria at the time of inclusion in 2008 will be invited for particpation. There are no new criteria for inclusion. They must be able to perform a reproducible lung function test. ;At the moment of inclusion in 2008 (OBAS 1.0) • For the asthma patients: physician diagnosed, persistent asthma > 2 years • Age > 18 and 35 kg/m2 • Ability to perform a reproducible lung function test

Exclusion criteria

Exclusion criteria: Patients will be excluded if they have other significant pulmonary pathology and if they are pregnant. ;At the moment of inclusion 2008 (OBAS 1.1) • Smoking > 10 sig/d or > 10 pack years (PY) • COPD or other pulmonary pathology apart from asthma. • Pregnancy • Exacerbation in 4 weeks prior to screening • Psychological instability

Design outcomes

Primary

MeasureTime frame
Asthma Control Questionnaire (ACQ) and Asthma Quality of Life Questionnaire (AQLQ) at 8 years after bariatric surgery.

Secondary

MeasureTime frame
• Lung function parameters: FEV1, FVC, FEV1/FVC TLC, FRC, reversibility. R5, X5 and Fres (IOS). • Airway hyperresponsiveness: PD20 (methacholine) • Airway inflammation: FeNO • Systemic inflammation (blood): TNF-a, IL-6, high sensitivity CRP, leptin and adiponectin • Asthma symptoms, exacerbation frequency, medication use

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)